| Item Type | Name |
|
Academic Article
|
Are we ready for regulation? ISHAGE Regulatory Action Group. International Society for Hematotherapy and Graft Engineering.
|
|
Academic Article
|
Stem cell isolation.
|
|
Academic Article
|
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.
|
|
Academic Article
|
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.
|
|
Academic Article
|
Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
|
|
Academic Article
|
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
|
|
Academic Article
|
Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
|
|
Academic Article
|
CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields.
|
|
Academic Article
|
Lymphocyte recovery predicts outcomes in cord blood and T cell-depleted haploidentical stem cell transplantation.
|
|
Academic Article
|
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
|
|
Academic Article
|
Evaluation and management of BK virus-associated nephropathy following allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.
|
|
Academic Article
|
Cord blood graft engineering.
|
|
Academic Article
|
Isolation of CD34-positive hematopoietic progenitor cells.
|
|
Academic Article
|
Bone marrow metastases.
|
|
Academic Article
|
Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction.
|
|
Academic Article
|
Clofarabine ? fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
|
|
Academic Article
|
Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement.
|
|
Academic Article
|
Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma.
|
|
Concept
|
Hematopoietic Stem Cells
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Hematopoietic Stem Cell Mobilization
|
|
Academic Article
|
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.
|
|
Academic Article
|
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
|
|
Academic Article
|
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy.
|
|
Academic Article
|
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.
|
|
Academic Article
|
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.
|
|
Academic Article
|
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.
|
|
Academic Article
|
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant.
|
|
Academic Article
|
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.
|
|
Academic Article
|
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
|
|
Academic Article
|
Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment.
|
|
Academic Article
|
Low rate of infusional toxicity after expanded cord blood transplantation.
|
|
Academic Article
|
Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
|
|
Academic Article
|
High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.
|
|
Academic Article
|
Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation.
|
|
Academic Article
|
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.
|
|
Academic Article
|
Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.
|
|
Academic Article
|
Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant.
|
|
Academic Article
|
Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer.
|
|
Academic Article
|
High-dose chemotherapy for breast cancer.
|
|
Academic Article
|
Ex-vivo purging of hematopoietic progenitor cells.
|
|
Academic Article
|
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
|
|
Academic Article
|
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
|
|
Academic Article
|
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
|
|
Academic Article
|
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
|
|
Academic Article
|
Cord blood stem cell therapy for acquired immune deficiency syndrome.
|
|
Academic Article
|
Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype.
|
|
Academic Article
|
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
|
|
Academic Article
|
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Does plerixafor destroy the hematopoietic progenitor cell/mesenchymal stromal cell niche?
|
|
Academic Article
|
Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant.
|
|
Academic Article
|
High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial.
|
|
Academic Article
|
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
|
|
Academic Article
|
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
|
|
Academic Article
|
Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice.
|
|
Academic Article
|
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
|
|
Academic Article
|
Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors.
|
|
Academic Article
|
Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood.
|
|
Academic Article
|
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation.
|
|
Academic Article
|
Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1.
|
|
Academic Article
|
The utilization of cytokines in stem cell mobilization strategies.
|
|
Academic Article
|
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.
|
|
Academic Article
|
Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
|
|
Academic Article
|
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.
|
|
Academic Article
|
Autologous stem-cell transplantation for solid tumors in adults.
|
|
Academic Article
|
A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
|
|
Academic Article
|
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.
|
|
Academic Article
|
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer.
|
|
Academic Article
|
Status of high-dose chemotherapy for breast cancer: a review.
|
|
Academic Article
|
American Society for Blood and Marrow Transplantation guidelines for training.
|
|
Academic Article
|
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
|
|
Academic Article
|
Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant.
|
|
Academic Article
|
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier.
|
|
Academic Article
|
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
|
|
Academic Article
|
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
|
|
Academic Article
|
Prognostic analysis of pre-transplant peripheral T-cell levels in patients receiving an autologous hematopoietic progenitor-cell transplant.
|
|
Academic Article
|
Umbilical cord blood-derived cells for tissue repair.
|
|
Academic Article
|
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
|
|
Academic Article
|
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.
|
|
Academic Article
|
Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT.
|
|
Academic Article
|
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
|
|
Academic Article
|
Ex vivo expansion of cord blood.
|
|
Academic Article
|
The 2011 education supplement on hematopoietic stem cell transplantation.
|
|
Academic Article
|
Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.
|
|
Academic Article
|
High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?
|
|
Academic Article
|
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
|
|
Academic Article
|
Umbilical cord blood transplantation: a maturing technology.
|
|
Academic Article
|
Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.
|
|
Academic Article
|
Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
|
|
Academic Article
|
Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
|
|
Academic Article
|
The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells.
|
|
Academic Article
|
Comparative assays of megakaryocyte progenitors in CD34+ peripheral blood progenitor cell fractions.
|
|
Academic Article
|
Dissemination and commercialization of hematopoietic progenitor cell transplantation.
|
|
Academic Article
|
Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer.
|
|
Academic Article
|
Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells.
|
|
Academic Article
|
High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial.
|
|
Academic Article
|
Mobilization and selection of CD34-positive hematopoietic progenitors.
|
|
Academic Article
|
Transplantation of CD34+ hematopoietic progenitor cells.
|
|
Academic Article
|
Peripheral blood stem cells for autografting.
|
|
Academic Article
|
Peripheral blood stem cell harvesting and CD34-positive cell selection.
|
|
Academic Article
|
American Society for Blood and Marrow Transplantation guidelines for training.
|
|
Academic Article
|
Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
|
|
Academic Article
|
Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
|
|
Academic Article
|
High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.
|
|
Academic Article
|
CD19 selection improves the sensitivity of B cell lymphoma detection.
|
|
Academic Article
|
Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery.
|
|
Academic Article
|
Empirical criteria for the selection of quality-of-life instruments for the evaluation of peripheral blood progenitor cell transplantation.
|
|
Academic Article
|
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
|
|
Academic Article
|
High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy.
|
|
Academic Article
|
Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support.
|
|
Academic Article
|
Peripheral blood stem cell transplantation in breast cancer.
|
|
Academic Article
|
Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft.
|
|
Academic Article
|
Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer.
|
|
Academic Article
|
Human pulmonary chimerism after hematopoietic stem cell transplantation.
|
|
Academic Article
|
Stem-cell transplantation for the treatment of advanced solid tumors.
|
|
Academic Article
|
Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies.
|
|
Academic Article
|
Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy.
|
|
Academic Article
|
Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells.
|
|
Academic Article
|
Strategies for widening the use of cord blood in hematopoietic stem cell transplantation.
|
|
Academic Article
|
Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
|
|
Academic Article
|
Phase I trial of parathyroid hormone to facilitate stem cell mobilization.
|
|
Academic Article
|
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.
|
|
Academic Article
|
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
|
|
Academic Article
|
Ex vivo expansion of umbilical cord blood for transplantation.
|
|
Academic Article
|
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
|
|
Academic Article
|
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.
|
|
Academic Article
|
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.
|
|
Academic Article
|
Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit.
|
|
Academic Article
|
Release of tumor cells from bone marrow.
|
|
Academic Article
|
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
|
|
Academic Article
|
Use of amifostine in bone marrow purging.
|
|
Academic Article
|
High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results.
|
|
Academic Article
|
Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer.
|
|
Academic Article
|
Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation.
|
|
Academic Article
|
Increased expansion and differentiation of cord blood products using a two-step expansion culture.
|
|
Academic Article
|
Renal dysfunction in allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia.
|
|
Academic Article
|
Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study.
|
|
Academic Article
|
Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
|
|
Academic Article
|
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type.
|
|
Academic Article
|
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
|
|
Academic Article
|
Transplantation of CD34+ hematopoietic progenitor cells.
|
|
Academic Article
|
High-dose chemotherapy for the treatment of breast and ovarian cancer.
|
|
Academic Article
|
High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
|
|
Academic Article
|
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support.
|
|
Academic Article
|
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
|
|
Academic Article
|
Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
|
|
Academic Article
|
Characterizing human herpes virus 6 following hematopoietic stem cell transplantation.
|
|
Academic Article
|
The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.
|
|
Academic Article
|
Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma.
|
|
Academic Article
|
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation.
|
|
Academic Article
|
Advances in umbilical cord blood manipulation-from niche to bedside.
|
|
Academic Article
|
Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations.
|
|
Academic Article
|
Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.
|
|
Academic Article
|
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
|
|
Academic Article
|
Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation.
|
|
Academic Article
|
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.
|
|
Academic Article
|
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
|
|
Academic Article
|
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation.
|
|
Academic Article
|
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
|
|
Academic Article
|
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of?Acute Myeloid Leukemia and Myelodysplastic Syndromes.
|
|
Academic Article
|
Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.
|
|
Academic Article
|
Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System.
|
|
Academic Article
|
Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes.
|
|
Academic Article
|
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients.
|
|
Academic Article
|
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application.
|
|
Academic Article
|
Utility of the Enzyme-Linked Immunospot Interferon-?-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients.
|
|
Academic Article
|
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell?Transplantation for Relapsed and Refractory Hodgkin?Lymphoma.
|
|
Academic Article
|
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
|
|
Academic Article
|
Non-fucosylated CB CD34+ cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantation.
|
|
Academic Article
|
Hematopoietic stem cells transplantation
|
|
Academic Article
|
Selection and transplantation of hematopoietic stem cells
|
|
Academic Article
|
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia
|
|
Academic Article
|
Autologous hematopoietic stem cell transplantation in breast cancer
|
|
Academic Article
|
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement
|
|
Academic Article
|
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia
|
|
Academic Article
|
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients
|
|
Academic Article
|
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma
|
|
Academic Article
|
Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma
|
|
Academic Article
|
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application
|
|
Academic Article
|
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
|
|
Academic Article
|
Hematopoietic stem cell transplantation
|
|
Academic Article
|
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.
|
|
Academic Article
|
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
|
|
Academic Article
|
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
|
|
Academic Article
|
Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement.
|
|
Academic Article
|
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation.
|
|
Academic Article
|
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia.
|
|
Academic Article
|
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
|
|
Academic Article
|
Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients.
|
|
Academic Article
|
Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
|
|
Academic Article
|
Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia.
|
|
Academic Article
|
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
|
|
Academic Article
|
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
|
|
Academic Article
|
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
|
|
Academic Article
|
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.
|
|
Academic Article
|
Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients.
|
|
Academic Article
|
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.
|
|
Academic Article
|
Prognostic Index for Critically Ill Allogeneic Transplantation Patients.
|
|
Academic Article
|
Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: The automated Sepax system versus the manual Ficoll method.
|
|
Academic Article
|
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.
|
|
Academic Article
|
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma.
|
|
Academic Article
|
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
|
|
Academic Article
|
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.
|
|
Academic Article
|
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
|
|
Academic Article
|
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes.
|
|
Academic Article
|
Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.
|
|
Academic Article
|
Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity.
|
|
Academic Article
|
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.
|
|
Academic Article
|
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
|
|
Academic Article
|
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.
|
|
Academic Article
|
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.
|
|
Academic Article
|
Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease.
|
|
Academic Article
|
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
|
|
Academic Article
|
Current and future status of stem cell expansion.
|
|
Academic Article
|
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.
|
|
Academic Article
|
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.
|
|
Academic Article
|
Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS.
|
|
Academic Article
|
HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
|
|
Academic Article
|
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens.
|
|
Academic Article
|
Cord Blood Expansion: A Clinical Advance.
|
|
Academic Article
|
Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial.
|
|
Academic Article
|
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
|
|
Academic Article
|
An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.
|
|
Academic Article
|
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
|
|
Academic Article
|
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation.
|
|
Academic Article
|
Unlicensed Umbilical Cord Blood Units Provide a Safe and Effective Graft Source for a Diverse Population: A Study of 2456 Umbilical Cord Blood Recipients.
|
|
Academic Article
|
Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis.
|
|
Academic Article
|
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
|
|
Academic Article
|
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors.
|
|
Academic Article
|
Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity.
|
|
Academic Article
|
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
|
|
Academic Article
|
Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL.
|
|
Academic Article
|
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients.
|
|
Academic Article
|
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
|
|
Academic Article
|
Guidelines for Cord Blood Unit Selection.
|
|
Academic Article
|
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma.
|
|
Academic Article
|
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.
|
|
Academic Article
|
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era.
|
|
Academic Article
|
Influence of Overlapping Genetic Abnormalities on Treatment Outcomes of Multiple Myeloma.
|
|
Academic Article
|
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease.
|
|
Academic Article
|
Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma.
|
|
Academic Article
|
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD.
|
|
Academic Article
|
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia.
|
|
Academic Article
|
Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis.
|
|
Academic Article
|
Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
|
|
Academic Article
|
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.
|
|
Academic Article
|
Decrease post-transplant relapse using donor-derived expanded NK-cells.
|
|
Academic Article
|
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.
|
|
Academic Article
|
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
|
|
Academic Article
|
Mismatch in SIRPa, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation.
|
|
Academic Article
|
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
|
|
Academic Article
|
Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
|
|
Academic Article
|
Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance.
|
|
Academic Article
|
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
|
|
Academic Article
|
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
|
|
Academic Article
|
Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure.
|
|
Academic Article
|
Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.
|
|
Academic Article
|
KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma.
|
|
Academic Article
|
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
|
|
Academic Article
|
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan???clofarabine in allogeneic stem cell transplantation.
|
|
Academic Article
|
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study Outcomes.
|
|
Academic Article
|
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
|
|
Academic Article
|
SIRPa Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies.
|
|
Academic Article
|
Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment.
|
|
Academic Article
|
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection.
|
|
Academic Article
|
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma.
|
|
Academic Article
|
Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant.
|
|
Academic Article
|
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease.
|
|
Academic Article
|
Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia.
|
|
Academic Article
|
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease?(MRD) recurrence following MRD-negative remission.
|
|
Academic Article
|
Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
|
|
Academic Article
|
Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia.
|
|
Academic Article
|
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission.
|
|
Academic Article
|
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant.
|
|
Academic Article
|
Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience.
|
|
Academic Article
|
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
|
|
Academic Article
|
Umbilical Cord Blood Transplantation: Connecting Its Origin to Its Future.
|
|
Academic Article
|
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
|
|
Academic Article
|
Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.
|
|
Academic Article
|
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation.
|
|
Academic Article
|
Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
|
|
Academic Article
|
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.
|
|
Academic Article
|
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
|
|
Academic Article
|
Outcomes of young adults (aged?=?40?years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant.
|
|
Academic Article
|
A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of Concept.
|
|
Academic Article
|
Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
|
|
Academic Article
|
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities.
|
|
Academic Article
|
Hematopoietic cell transplantation can be safely performed after COVID-19.
|
|
Academic Article
|
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
|
|
Academic Article
|
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma.
|
|
Academic Article
|
Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma.
|
|
Academic Article
|
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
|
|
Academic Article
|
Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy.
|
|
Academic Article
|
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma.
|
|
Academic Article
|
A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke.
|
|
Academic Article
|
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
|
|
Academic Article
|
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
|
|
Academic Article
|
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
|
|
Academic Article
|
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial.
|
|
Academic Article
|
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.
|
|
Academic Article
|
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
|
|
Academic Article
|
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
|
|
Academic Article
|
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
|